Based on these trial results, Lilly will begin enrolling Phase 3 clinical studies for the treatment of obesity next month INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced positive […]
Tag: Eli Lilly and Company
Using the original title “Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States”, create a new title that is SEO-optimized, engaging, and fewer than 15 words. Incorporate the main focus keyword naturally and ensure the title accurately reflects the essence of the original. Do not include any part of this prompt or instructions in your response. Only provide the rewritten title. Avoid using the phrases: “rewrite,” “rewrite the title,” or “rewrite the following content.”
Transform the following content into a 1,500-word article: Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs INDIANAPOLIS, Oct. 29, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today […]
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs INDIANAPOLIS, Oct. 29, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today a planned investment of more than $1.2 billion […]
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
New AI capabilities will help scientists identify, optimize and validate new molecules Additional applications include manufacturing, medical imaging and enterprise AI agents INDIANAPOLIS, Oct. 28, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced […]
Lilly to Acquire Adverum Biotechnologies
Adverum’s lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition aligns Lilly’s genetic medicine capabilities with opportunity to […]
